NASDAQ$HCAT
Health Catalyst Inc · Q2 2020 earnings
Q2 2020 earnings · · Investor relations
Briefing
Reported financial results, outperforming revenue and Adjusted EBITDA guidance, and team member satisfaction ranked in the 99th percentile.
Health Catalyst reported strong financial results for Q2 2020, exceeding revenue and Adjusted EBITDA guidance. Team member satisfaction remained high, and the company is hosting its annual Healthcare Analytics Summit virtually in September.
- Total revenue for the quarter ended June 30, 2020, was $43.259 million, an 18% increase year-over-year.
- Technology revenue increased by 27% year-over-year, reaching $25.487 million.
- The company's team member overall satisfaction score ranked in the 99th percentile.
- Health Catalyst is hosting its seventh annual Healthcare Analytics Summit in September, focusing on healthcare analytics in the 'new normal'.
Headline financials
Revenue & EPS history
Health Catalyst · Revenue · Quarterly
$43.3M
Revenue by segment
Health Catalyst · $73.8M total across 2 segments · Q3 2023
- Technology$46M+4.5%62.3%
- Professional Services$27.8M+14.1%37.7%
Forward guidance
Health Catalyst provides forward-looking guidance on total revenue and Adjusted EBITDA. For the third quarter of 2020, the company expects total revenue between $43.0 million and $46.0 million, and Adjusted EBITDA between $(8.9) million and $(6.9) million. For the full year of 2020, the company expects total revenue between $177.2 million and $181.2 million, and Adjusted EBITDA between $(25.5) million and $(22.5) million.
Tailwinds
- Total revenue between $43.0 million and $46.0 million for Q3 2020
- Adjusted EBITDA between $(8.9) million and $(6.9) million for Q3 2020
- Total revenue between $177.2 million and $181.2 million for the full year 2020
- Adjusted EBITDA between $(25.5) million and $(22.5) million for the full year 2020
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2020
-3.1%
Avg return
Earnings day
-3.9%
Avg return
5 days after
-4.0%
Avg return
30 days after
41%
11 / 27 earnings
Positive
+27.3%
Q2 2024
Best reaction
-36.6%
Q2 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -9.9% | -21.7% | +4.6% | |
| Q4 2025 | -26.3% | -35.2% | -44.4% | |
| Q3 2025 | -5.6% | -20.5% | -10.2% | |
| Q1 2025 | +5.3% | +8.1% | +3.3% | |
| Q4 2024 | -11.1% | -8.5% | -7.9% | |
| Q3 2024 | +14.2% | +7.2% | +7.6% | |
| Q2 2024 | +27.3% | +7.3% | +22.9% | |
| Q1 2024 | -3.6% | +2.9% | -2.3% | |
| Q4 2023 | -14.7% | -8.9% | -14.4% | |
| Q3 2023 | +5.1% | -0.4% | +5.3% | |
| Q2 2023 | -8.0% | -5.0% | -12.4% | |
| Q1 2023 | -18.9% | -14.8% | -4.3% | |
| Q4 2022 | +7.3% | +5.8% | -14.8% | |
| Q3 2022 | +16.2% | +42.9% | +59.2% | |
| Q2 2022 | -36.6% | -34.7% | -35.9% | |
| Q1 2022 | -2.6% | +24.6% | +10.5% | |
| Q4 2021 | +1.5% | -7.1% | -3.7% | |
| Q3 2021 | -6.2% | -6.1% | -26.9% | |
| Q2 2021 | +1.5% | -2.3% | -2.8% | |
| Q1 2021 | -2.3% | -8.6% | -2.4% | |
| Q4 2020 | +0.6% | +0.1% | -2.1% | |
| Q3 2020 | -0.2% | -3.5% | +6.2% | |
| Q2 2020 | -7.2% | -10.9% | -3.4% | |
| Q1 2020 | -1.9% | -0.5% | -5.0% | |
| Q4 2019 | +1.3% | -5.8% | -20.1% | |
| Q3 2019 | +1.9% | -0.8% | -1.1% | |
| Q2 2019 | -11.5% | -7.8% | -13.1% | |
| Q4 2018 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro